In label expansion bid, AbbVie and Roche's Venclexta falls short in multiple myeloma subset
29th September 2023 Uncategorised 0 In label expansion bid, AbbVie and Roche’s Venclexta falls short in multiple myeloma subset
zbecker
Fri, 09/29/2023 – 10:53
More: In label expansion bid, AbbVie and Roche's Venclexta falls short in multiple myeloma subset
Source: fierce